0001654954-23-015564.txt : 20240118 0001654954-23-015564.hdr.sgml : 20240118 20231214170851 ACCESSION NUMBER: 0001654954-23-015564 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ainos, Inc. CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 858-869-2986 MAIL ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 FORMER COMPANY: FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC DATE OF NAME CHANGE: 19960516 CORRESP 1 filename1.htm aimd_corresp
 
Ainos, Inc.
8880 Rio San Diego Drive, Ste. 800
San Diego, CA 92108
 
 
December 14, 2023
 
 VIA EDGAR
 
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
 
             
Re:     
Ainos, Inc.
Registration Statement on Form S-1
(File No. 333-275971)
 
Ladies and Gentlemen:
 
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Ainos, Inc., a Texas corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-275971), initially filed with the U.S. Securities and Exchange Commission on December 8, 2023, be accelerated so that the registration statement becomes effective at 5:30 p.m. Eastern Time on December 18, 2023, or as soon thereafter as practicable.
 
If you have any questions or comments, please contact Carol Stubblefield of Baker McKenzie LLP at (212) 626 4729.
 
 
Very truly yours,
 
 
AINOS, INC.
 
 
 
By: /s/ Chun-Hsien Tsai                                                                
Chun-Hsien Tsai
Chief Executive Officer